Publications des scientifiques de l'IRD

Sanchez L. V., Pla D., Herrera M., Chippaux Jean-Philippe, Calvete J. J., Gutierrez J. M. (2015). Evaluation of the preclinical efficacy of four antivenoms, distributed in sub-Saharan Africa, to neutralize the venom of the carpet viper, Echis ocellatus, from Mali, Cameroon, and Nigeria. Toxicon, 106, p. 97-107. ISSN 0041-0101.

Titre du document
Evaluation of the preclinical efficacy of four antivenoms, distributed in sub-Saharan Africa, to neutralize the venom of the carpet viper, Echis ocellatus, from Mali, Cameroon, and Nigeria
Année de publication
2015
Type de document
Article référencé dans le Web of Science WOS:000364252400013
Auteurs
Sanchez L. V., Pla D., Herrera M., Chippaux Jean-Philippe, Calvete J. J., Gutierrez J. M.
Source
Toxicon, 2015, 106, p. 97-107 ISSN 0041-0101
Snakebite envenoming causes a heavy toll in sub-Saharan Africa in terms of mortality and sequelae. In the West African savannah, the viperid Echis ocellatus is responsible for the vast majority of bites. In the last decades, several new antivenoms have been introduced for the treatment of these envenomings, although the assessment of their preclinical efficacy against the venom of E. ocellatus has been studied only for some of them. This work analyzed comparatively the ability of four antivenoms (FAV Afrique, EchiTAb G, EchiTAB-Plus-ICP (R), and Inoserp (TM) Panafricain) to neutralize lethal, hemorrhagic, and in vitro coagulant activities of the venoms of E. ocellatus from Mali, Cameroon, and Nigeria. In addition, an immunoaffinity chromatography antivenomic protocol was used to assess the ability of the four antivenoms to bind to the proteins of these venoms. Results showed that all the antivenoms were effective in the neutralization of the three effects investigated, and were able to immunocapture, completely or partially, the most abundant components in the E. ocellatus venoms from the geographical origins sampled. Our observations also highlighted quantitative differences between antivenoms in their neutralizing and antivenomics profiles, especially regarding neutralization of in vitro coagulant activity, suggesting that different doses of these antivenoms are probably needed for an effective treatment of human envenomings by this species.
Plan de classement
Santé : généralités [050]
Description Géographique
MALI ; CAMEROUN ; NIGERIA
Localisation
Fonds IRD [F B010065435]
Identifiant IRD
fdi:010065435
Contact